Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological disease that affects the nerve cells in the brain and spinal cord, leading to muscle weakness, difficulty speaking, and eventually loss of mobility.
Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis
We are studying a new treatment using neural stem cells for people with ALS. The trial aims to assess safety and whether it may help slow disease progression.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 65 years old?
- Do you have a diagnosis of ALS (amyotrophic lateral sclerosis)?
- Are you currently taking Riluzole or have you taken it in the last 30 days?
- Are you pregnant or breastfeeding?
- Have you had any cancer in the last 10 years?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Azienda Ospedaliero-Universitaria Maggiore Della Carita
Centro SLA
Novara, Italy
Azienda Ospedaliera di Padova
Dipartimento Strutturale Aziendale Neuroscienze e Organi di Senso
Padova, Italy
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Centro SLA
Palermo, Italy
Sponsor: Casa Sollievo Della Sofferenza
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.